This session examines how advanced artificial intelligence is reshaping diagnostics, early detection, and personalised healthcare. As AI systems increasingly outperform traditional methods in identifying patterns, predicting disease progression, and supporting clinical decision-making, they offer significant potential to improve patient outcomes, reduce system pressures, and enable more proactive models of care.

The discussion will explore current breakthroughs, real-world applications, and the integration of machine learning across clinical workflows. Panellists will assess the ethical, regulatory, and data-governance considerations that underpin trustworthy AI, alongside challenges of interoperability, bias mitigation, and clinical validation.

As the science of longevity advances, health is no longer defined by disease management alone but by proactive optimization of body, mind, and environment. This session explores how biohacking, functional medicine, and personalized health strategies empower individuals to enhance vitality, resilience, and long-term wellbeing.

Experts from medical, integrative, and diagnostic fields will discuss the role of biomarkers, wearable technology, lifestyle design, nutrition, movement, and stress regulation in extending healthspan. The conversation will also highlight how wellness-centered living environments, preventive care models, and holistic lifestyle practices support healthier aging and sustainable quality of life.

Attendees will gain practical insights into integrating science-backed longevity strategies with modern lifestyles to achieve optimal health and lasting vitality.

This session examines how robotics-assisted surgery is redefining clinical precision, workflow efficiency, and patient outcomes across modern healthcare systems. As digital innovation advances, surgical robots, enhanced imaging, and AI-supported navigation are enabling minimally invasive procedures with greater accuracy, reduced recovery times, and improved overall care quality.

Panellists will discuss current technological capabilities, adoption strategies, and the integration of robotics into surgical pathways.

According to W.H.O., reversible chronic health/medical disorders contribute to about 42m premature death per year. More than 70% of health budgets in most countries including Malaysia are spent in treating the symptoms of these chronic metabolic disorders including diabetes, hypertension, dyslipidemia, arthrosclerosis, and cancer.

Nutritional and Functional Medicine (NFM) is a major treatment specialty within non-drug complementary medicine, which is growing at the rate of 25% annually. Its natural adjunct treatment for chronic disorders is non-invasive involving evidence-based nutraceuticals and dietary/lifestyle modifications.

About 70% of Malaysians have used some forms of NFM in their lives. The speaker shares his 25-year clinical experience in using NFM for managing and even reversing the common but major chronic disorders facing Malaysians today.

This session explores how strategic human capital policies can drive sustainable, high-performing healthcare systems. As hospitals and health networks navigate workforce shortages, evolving skills demands, and rising service expectations, investing in people becomes central to long-term resilience and improved patient outcomes.

Panellists will examine approaches to workforce planning, continuous professional development, talent retention, and leadership cultivation, alongside the role of digital upskilling in enabling more efficient and agile care delivery. The discussion will also consider policy levers that support equity, staff wellbeing, and collaborative, team-based models of care.

This session explores how regulatory systems are evolving to keep pace with rapid scientific innovation and increasing global interconnectedness. As advanced therapeutics, complex biologics, and data-driven submissions reshape the pharmaceutical landscape, regulators are strengthening accelerated approval pathways, reliance frameworks, and digital processes to enhance efficiency while upholding rigorous standards of safety, quality, and efficacy. The discussion will also reflect on the importance of GMP compliance, PIC/S engagement, and international alignment in facilitating market access, reinforcing regulatory trust, and enabling faster, responsible patient access to safe and innovative medicines across Malaysia and ASEAN.

This session explores how Japan’s advanced elder-care ecosystem offers valuable insights for countries confronting rapid population ageing. Japan’s integrated networks—combining medical care, long-term support, rehabilitation, community-based services, and wellness-focused programmes—demonstrate how coordinated models can enhance quality of life, reduce caregiver burden, and optimise resource utilisation.

Workplace wellness has become an essential priority for organizations seeking to improve employee health, productivity, and overall organizational performance. Lifestyle Medicine offers a comprehensive, evidence-based approach that focuses on preventing and managing chronic diseases through sustainable lifestyle behaviors. By addressing key factors such as nutrition, physical activity, sleep, stress management, avoidance of harmful substances, and positive social connections, lifestyle medicine provides a proactive framework for improving employee wellbeing.

Many common health conditions affecting the workforce, including Type 2 Diabetes, Cardiovascular Disease, Hypertension, and Obesity, are strongly linked to poor lifestyle habits and workplace environments. Integrating lifestyle medicine principles into workplace wellness programs can help reduce the prevalence of chronic diseases, lower healthcare costs, decrease absenteeism and presentism while improving employee engagement and productivity.

Furthermore, organizations that adopt lifestyle-focused wellness strategies create healthier workplace cultures that support long-term behavior change. Through initiatives such as healthy food options, opportunities for physical activity, stress-reduction programs, and education on healthy living, employers can empower employees to make positive lifestyle choices. Consequently, lifestyle medicine has the potential to transform workplace wellness by shifting the focus from reactive healthcare to preventive, holistic wellbeing that benefits both employees and organizations.

This session explores the emerging potential of plant-based immunotherapy as a complementary pathway for recovery and disease management. Drawing on advances in phytomedicine, bioactive compounds, and integrative oncology, plant-derived immunomodulators are increasingly being investigated for their ability to enhance immune response, reduce treatment side effects, and support overall patient resilience. The session will examine current scientific evidence, clinical applications, and ongoing research into plant-based immunotherapeutics, alongside patient-centred approaches that empower individuals to take a more active role in their healing journey.

Health research can be approached from two main perspectives: pathogenic and salutogenic. Pathogenic research explores to understand the causes and development of diseases within the physiological organism, aiming primarily to identify medical treatments. On the other hand, salutogenic research focuses on identifying factors that maintain and promote health, rather than just investigating disease-causing factors. Together, these approaches provide a comprehensive understanding of health and disease, aiming to answer the salutogenic question: what factors contribute to both creating and sustaining health? The principles of salutogenic design extend beyond mere support for the healing process; they aim to actively promote health and well-being across various types of buildings. Salutogenesis forms the foundation of a healthy society, seeking to efficiently reduce the burden of lifestyle diseases. This requires significant investments in health promotion and the prevention of non-communicable diseases. Our society faces significant challenges, particularly concerning the cognitive struggles experienced by a substantial portion of the elderly population. Unfortunately, public-space design guidelines often neglect their needs, highlighting broader shortcomings in addressing dementia and fostering healthy communities. Transitioning towards a salutogenic healthcare model requires a fundamental shift, prioritizing the bio-psycho-social needs of individuals and communities within dynamic environments. Adopting salutogenic approaches in the built environment, infrastructure investment, and development embeds preventative care at the core, shifting focus from treating diseases to understanding and enhancing wellness factors. Incorporating abundant greenery not only promotes physical activity, reducing the risk of cardiovascular diseases, stroke, diabetes, and falls in the elderly, but also contributes to mental well-being by reducing stress and mental fatigue. Creating attractive and supportive environments ultimately improves the burden of disease, potentially reducing healthcare costs and reinforcing societal resilience. By shaping the salutogenic built environment, we can proactively promote health and prevent stress, fostering a healthier and more sustainable living.

This session explores how digital technologies are reshaping cancer care across the entire patient journey—from early detection and diagnosis to treatment planning, monitoring, and survivorship support. Advances in AI-driven imaging, genomic profiling, tele-oncology, remote monitoring, and precision medicine are delivering new levels of accuracy, personalisation, and continuity of care.

By offering practical insights for both patients and practitioners, the discussion aims to clarify how digital innovation can strengthen cancer outcomes, support shared decision-making, and prepare healthcare systems for the next generation of oncology care.

This session examines how Asia's health tourism sector is evolving in response to global shifts in patient expectations, medical innovation, and cross-border mobility. As demand rises for high-quality, affordable, and experience-driven healthcare services, Asian destinations are positioning themselves as leading hubs for specialised treatment, wellness programmes, and integrated recovery pathways.

Medical tourism is entering a defining phase of transformation. What was once driven by treatment-focused travel is now evolving into a more intelligent, connected, and experience-led global health ecosystem. Artificial intelligence is at the center of this shift, enabling healthcare providers and destinations to move beyond episodic care toward integrated, preventive, and personalized health journeys.

This session explores how AI is redefining medical tourism by bridging clinical care with integrated wellness experiences and long-term preventive health strategies. It will examine how patient journeys are being redesigned through data-driven personalization, predictive insights, and continuous engagement across every stage, from discovery and decision-making to recovery and beyond.

Drawing from global industry experience, the session will highlight how forward-thinking organizations are transitioning from transactional service models to more holistic and value-driven approaches. The focus will be on creating seamless ecosystems where medical care, wellness, and preventive interventions work together to enhance outcomes and patient trust.

Participants will gain clear strategic direction on how to integrate AI into their patient journey design, develop wellness-led offerings that complement clinical excellence, and reposition their services for a future where prevention, personalization, and experience define success in global healthcare.

This presentation explores neurodivergence through a systems-based health framework, examining how neurological development is influenced by early developmental sequencing, metabolic health, environmental inputs, and biological regulation.

Rather than focusing solely on behavioural labels such as ADHD or autism spectrum conditions, this session examines the physiological drivers that influence brain development and regulation — including retained primitive reflexes, gut-brain signalling, mitochondrial health, and environmental stressors.

Using clinical insights and laboratory data from advanced functional testing platforms including Gut Zoomer and Neural Zoomer, the presentation demonstrates how immune activation, microbiome disruption, and neuroinflammatory processes can influence cognitive function, emotional regulation, and developmental outcomes.

The session introduces the Physically Primal framework, which integrates developmental neurology, movement sequencing, metabolic optimization, and emerging therapeutic technologies to support neurological resilience across the lifespan.

Most men are taught to perform: hit targets, stay strong, push harder, get results, fast. But behind the drive, there's a question few dare to ask:

Where is your ambition coming from, fear or truth?

In a world addicted to shortcuts, comfort, and constant validation, many high achievers unknowingly build their leadership, health, and identity on insecurity: the fear of not being enough, the fear of rejection, the need to prove, and the pressure to fit the mold.

This talk cuts through the noise and takes you to the root, your beliefs, behaviours, and emotional drivers, so you can see what's actually powering your "success".

You'll leave with practical daily tools and an actionable protocol to shift from performance to alignment, from chasing worth to embodying it. So your leadership becomes grounded, your wellbeing becomes sustainable, and your impact becomes real.

This session examines the rapid evolution of the global wellness economy as it expands beyond traditional health and fitness sectors into a multidimensional ecosystem encompassing preventive care, mental wellbeing, nutrition, technology, workplace wellness, and sustainable lifestyle solutions. As consumer priorities shift towards holistic health and long-term resilience, wellness has become a defining driver of economic growth, innovation, and cross-sector collaboration.

By providing strategic insights into future directions, the session aims to equip stakeholders with a clearer understanding of how to capture value, strengthen societal wellbeing, and advance a sustainable, inclusive global wellness economy.